Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which promises results in 30 minutes—for myself.

And CDC data collected prior to January from states including Ohio shows that norovirus has already caused nearly 500 ...

Unless they’re covering me in a cloud of norovirus particles. When the violent expelling of liquid starts somewhere other ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

The virus, often colloquially referred to as “stomach flu,” saw the percentage of positive tests double during the first week ...

Norovirus is surging across the U.S., with case numbers higher now than they've been at the same time in more than a decade, according to the U.S. Centers for Disease Control and Prevention (CDC ...

Many respiratory viruses, including Influenza, RSV and COVID-19, can cause cold-like symptoms,” state health officials said.

Norovirus outbreaks are also spreading across ... Health officials believe the popularity of at-home rapid-test kits for COVID-19, like these provided free by the federal government, means actual ...

yet several norovirus-like outbreaks have been reported in over a dozen states including Virginia. A January 3 situation update from the VDH Office of Emergency Management showed test positivity ...